Importantly, at day 26, serum analysis of Db-scTRAIL in animals receiving MSC.TRAIL revealed a concentration of ~1.5 ng/ml (Figure 5C) supporting a direct correlation of TRAIL activity and tumor reduction. Here, TNFSF10 is linked to neoplasm.